Prof. Wei Huang | Metabolism | Research Excellence Award

Doctor | The Affiliated Hospital of Southwest Medical University | China

Wei Huang, a researcher specializing in endocrinology, immunometabolism, and molecular pathophysiology, serves as a leading scholar at his institution, contributing extensively to the study of diabetes, diabetic complications, and epigenetic regulation. Holding advanced degrees in biomedical and life sciences with a focus on metabolic disorders, he has developed a strong academic foundation that supports his multidisciplinary research. His professional experience includes leading and collaborating on numerous projects exploring histone post-translational modifications, inflammatory signaling, kidney injury mechanisms, and metabolic disease therapeutics, alongside active roles in guiding research teams and contributing to scientific program development. Dr. Huang’s research centers on molecular pathways underlying chronic metabolic diseases, with significant contributions to understanding short-chain fatty acids, β-hydroxybutyrate, inflammasome activation, and autophagy regulation; he has produced an extensive body of work comprising over seventy publications with high citation impact, reflecting sustained influence across biomedical research fields. He has received recognitions for scientific excellence and contributes to the global research community through verified peer review for leading journals, editorial responsibilities, and active membership in professional networks. His commitment to advancing medical science is further demonstrated by his engagement in interdisciplinary collaborations and his role in disseminating high-quality scientific knowledge. His publication metrics include a 30 h-index and 2,570 citations, underscoring his scholarly impact.

Profile: ORCID

Featured Publications

Wei Huang*, Employment at the Affiliated Hospital of Luzhou Medical College, Department of Endocrinology, Luzhou, Sichuan, CN. ORCID: 0000-0002-9744-8762, Profile ID: 201732.

Wei Huang*, Academic training at Luzhou Medical College, Department of Endocrinology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, CN. Education, Completed.

Wei Huang, Peer review activity covering Ageing Research Reviews (4 reviews). Ageing Res. Rev., Review Contribution.

Wei Huang, Peer review activity for Biochemical Pharmacology (2 reviews). Biochem. Pharmacol., Review Contribution.

Wei Huang, Peer review activity for Genes & Diseases (1 review). Genes Dis., Review Contribution.

Wei Huang, Peer review activity for Heliyon (1 review). Heliyon, Review Contribution.

Wei Huang, Peer review activity for Signal Transduction–related publications (1 review). Signal Transduct., Review Contribution.

Assoc. Prof. Dr. Bing Yao | Genetics | Best Researcher Award

Associate Professor | Nanjing Medical University | China

Dr. Bing Yao is a Professor and Deputy Director of the Experimental Teaching Center at Nanjing Medical University, specializing in tumor biology with a focus on metal-dependent cell death and epigenetic regulation mechanisms in cancer. He earned his Ph.D. from the School of Life Sciences at Nanjing University, where he developed a strong foundation in molecular biology and cancer genetics. Dr. Yao has led multiple research projects funded by the National Natural Science Foundation of China and other national programs, advancing understanding of molecular pathways driving tumor resistance and progression. His pioneering studies on ferroptosis, cuproptosis, and chromatin modification have been published in leading international journals, including Cancer Cell, Advanced Science, Cell Reports, Genome Medicine, and Molecular Cancer, where he has served as senior or corresponding author. In recognition of his outstanding scientific achievements, he has received numerous honors such as the Jiangsu Provincial Science and Technology Award, the Youth Science and Technology Talent Support Program, and the Excellent Young Backbone Teacher Award under the “Qinglan Project.” Dr. Yao is also actively involved in academic mentorship, guiding students who have won multiple national and international innovation awards. His editorial roles, professional memberships, and certifications further reflect his leadership and commitment to advancing biomedical research and education in oncology and molecular medicine.

Profile: ORCID

Featured Publications

Bing Yao*, PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med., 2021, 13(1), 71.

Bing Yao*, CircEZH2/miR133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA. Mol. Cancer, 2022, 21(1), 140.

Bing Yao*, KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc. Clin. Transl. Med., 2024, e1573.

Bing Yao*, The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Mol. Cancer, 2022, 21(1), 119.